GlassScriptPhysician profile
Lakshmi Sridharan
NPI 1376834408
$17,229.84
in general payments reported to CMS, 2019-2025
4 companies · $6,056 in 2025
The $6,056 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.76 · 2024: $11K · 2025: $6,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $9,600 · Consulting Fee: $5,728 · Travel and Lodging: $1,394 · Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $9,600.00 |
| Consulting Fee | $5,728.00 |
| Travel and Lodging | $1,393.93 |
| Food and Beverage | $492.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $11,262.74 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $5,917.65 | 2025 | |
| Edwards Lifesciences Corporation | $33.69 | 2024 | Hemosphere |
| Abbott Laboratories | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lakshmi Sridharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.